Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Pfizer Begins 2018 With Two Deals, Including ALS Tie-Up With Sangamo

Jan 04 2018

• By Joseph Haas and Ying Huang

DealWatch_1200x675

Related Content

Roche Ramps Up Cancer Portfolio With $1.7bn Ignyta Buy

Dec 22 2017

Genexine Seals I-O Licensing Deal With I-Mab, Builds Momentum

Dec 26 2017

Mallinckrodt Reduces Acthar Reliance With $1.2bn Sucampo Buy

Dec 27 2017

Related Companies

Pfizer Inc.

Sangamo Therapeutics, Inc.

Arvinas, Inc.

Merck & Co., Inc.

Genentech, Inc.

AstraZeneca PLC

ANI Pharmaceuticals, Inc.

Summit Therapeutics Inc.

Summit Therapeutics Inc.

Eurofarma Laboratorios S.A.

Inovio Pharmaceuticals, Inc.

ApolloBio Corporation

Array BioPharma, Inc.

ASLAN Pharmaceuticals

TRACON Pharmaceuticals Inc.

Ambrx Biopharma, Inc.

Five Prime Therapeutics, Inc.

Zai Lab Ltd.

Tesaro, Inc.

Onconova Therapeutics, Inc.

HanX Biopharmaceuticals, Inc.

Pfizer Inc.

Otsuka Holdings Co., Ltd.

X-Chem, Inc.

Mallinckrodt plc

Mallinckrodt plc

Genexine Inc.

I-Mab

Roche Holding AG

Ignyta, Inc.

Loxo Oncology at Lilly

Bayer AG

Additional Topics

Deals Business Strategies M & A BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window